It's important to be clear that we're not talking about preferential access, nor are we talking about any barrier to required or necessary medicines for those on public insurance. What we're talking about, as one example, is the difference between a generic and a national brand medicine. Some people may continue to prefer that recognized brand, but as most clinicians are aware, those medicines are effectively identical.
